BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17586489)

  • 1. Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice.
    Adamek A; Jung S; Dienesch C; Laser M; Ertl G; Bauersachs J; Frantz S
    Eur J Pharmacol; 2007 Sep; 571(1):51-4. PubMed ID: 17586489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury.
    Frantz S; Tillmanns J; Kuhlencordt PJ; Schmidt I; Adamek A; Dienesch C; Thum T; Gerondakis S; Ertl G; Bauersachs J
    Am J Pathol; 2007 Aug; 171(2):507-12. PubMed ID: 17556593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
    Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
    Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders.
    Honda T; Kaikita K; Tsujita K; Hayasaki T; Matsukawa M; Fuchigami S; Sugiyama S; Sakashita N; Ogawa H; Takeya M
    J Mol Cell Cardiol; 2008 May; 44(5):915-26. PubMed ID: 18436235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice.
    Hu C; Chen J; Dandapat A; Fujita Y; Inoue N; Kawase Y; Jishage K; Suzuki H; Li D; Hermonat PL; Sawamura T; Mehta JL
    J Mol Cell Cardiol; 2008 Jan; 44(1):76-83. PubMed ID: 18022184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic deletion of fas receptors or Fas ligands does not reduce infarct size after acute global ischemia-reperfusion in isolated mouse heart.
    Tekin D; Xi L; Kukreja RC
    Cell Biochem Biophys; 2006; 44(1):111-7. PubMed ID: 16456239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
    Liu XM; Jia Z; Zhou ZQ; Xu JG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2463-7. PubMed ID: 18067805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment.
    Shibata R; Sato K; Kumada M; Izumiya Y; Sonoda M; Kihara S; Ouchi N; Walsh K
    Cardiovasc Res; 2007 Jun; 74(3):471-9. PubMed ID: 17362898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury.
    Frantz S; Adamek A; Fraccarollo D; Tillmanns J; Widder JD; Dienesch C; Schäfer A; Podolskaya A; Held M; Ruetten H; Ertl G; Bauersachs J
    Basic Res Cardiol; 2009 Nov; 104(6):773-9. PubMed ID: 19548059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 12/15 lipoxygenase by baicalein reduces myocardial ischemia/reperfusion injury via modulation of multiple signaling pathways.
    Song L; Yang H; Wang HX; Tian C; Liu Y; Zeng XJ; Gao E; Kang YM; Du J; Li HH
    Apoptosis; 2014 Apr; 19(4):567-80. PubMed ID: 24248985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury.
    Roubille F; Combes S; Leal-Sanchez J; Barrère C; Cransac F; Sportouch-Dukhan C; Gahide G; Serre I; Kupfer E; Richard S; Hueber AO; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2007 Dec; 116(23):2709-17. PubMed ID: 18025529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effect of 5-lipoxygenase gene (ALOX5) silencing in ischemia-reperfusion.
    Lisovyy OO; Dosenko VE; Nagibin VS; Tumanovska LV; Korol MO; Surova OV; Moibenko OO
    Acta Biochim Pol; 2009; 56(4):687-94. PubMed ID: 20011686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats.
    Zhou Y; Wei EQ; Fang SH; Chu LS; Wang ML; Zhang WP; Yu GL; Ye YL; Lin SC; Chen Z
    Life Sci; 2006 Sep; 79(17):1645-56. PubMed ID: 16824548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-alpha.
    Esposito E; Mazzon E; Muià C; Meli R; Sessa E; Cuzzocrea S
    J Leukoc Biol; 2007 Apr; 81(4):1032-43. PubMed ID: 17210619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction.
    Favre J; Musette P; Douin-Echinard V; Laude K; Henry JP; Arnal JF; Thuillez C; Richard V
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1064-71. PubMed ID: 17332486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple-site activation of the cysteinyl leukotriene receptor 2 is required for exacerbation of ischemia/reperfusion injury.
    Ni NC; Ballantyne LL; Mewburn JD; Funk CD
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):321-30. PubMed ID: 24285579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor beta mediates acute myocardial protection following ischemia.
    Wang M; Crisostomo PR; Markel T; Wang Y; Lillemoe KD; Meldrum DR
    Surgery; 2008 Aug; 144(2):233-8. PubMed ID: 18656630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective 5-LOX inhibitor 11-keto-β-boswellic acid protects against myocardial ischemia reperfusion injury in rats: involvement of redox and inflammatory cascades.
    Elshazly SM; Abd El Motteleb DM; Nassar NN
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Sep; 386(9):823-33. PubMed ID: 23771412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvia miltiorrhiza treatment during early reperfusion reduced postischemic myocardial injury in the rat.
    Nie R; Xia R; Zhong X; Xia Z
    Can J Physiol Pharmacol; 2007 Oct; 85(10):1012-9. PubMed ID: 18066102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-protective effects of pentraxin 3 produced from bone marrow-derived cells against ischemia/reperfusion injury.
    Shimizu T; Suzuki S; Sato A; Nakamura Y; Ikeda K; Saitoh S; Misaka S; Shishido T; Kubota I; Takeishi Y
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):306-13. PubMed ID: 26470821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.